Katatonie im Wandel der Zeit – von Kahlbaum bis zum ICD-11

Das psychomotorische Syndrom der Katatonie galt über Jahrzehnte ausschließlich als Subtyp der Schizophrenie. Der Einsatz von Antipsychotika und Veränderungen der Lehrinhalte in der Weiterbildung von Psychiatern führten dazu, dass Katatonien kaum noch erkannt wurden. Dabei ist die Katatonie prinzipiell gut behandelbar. Der neue Status in der ICD-11 ermöglicht uns wahrscheinlich, die Katatonie künftig besser zu lehren, zu erkennen und zu behandeln.

Abstract

For decades, the psychomotor syndrome of catatonia was considered exclusively a subtype of schizophrenia. The use of antipsychotics and changes in the teaching content in the further training of psychiatrists led to the fact that catatonia was hardly recognized anymore. Yet catatonia is in principle well treatable. The new status in ICD-11 will probably allow to better teach, recognize, and treat catatonia in the future.

Schlüsselwörter

psychomotorisches Syndrom - Schizophrenie - Antipsychotika - ICD-11 - Klassifikationssysteme - affektive Störungen - Autismus - organische Störungen

Key words

psychomotor syndrome - schizophrenia - antipsychotics - ICD-11 - classification systems - affective disorders - autism - organic disorders

Publication History

Article published online:
24 January 2023

• Literatur

• 1 Fink M, Taylor MA. Catatonia: A Clinicianʼs Guide to Diagnosis and Treatment. Cambridge: University Press; 2006
• 2 Walther S, Strik W. Motor symptoms and schizophrenia. Neuropsychobiol 2012; 66: 77-92 DOI: 10.1159/000339456.
• 3 Wortzel JR, Maeng DD, Francis A. et al. Prevalent gaps in understanding the features of catatonia among psychiatrists, psychiatry trainees, and medical students. J Clin Psychiatry 2021; 82: 21m14025 DOI: 10.4088/JCP.21m14025.
• 4 Kendler KS. Phenomenology of schizophrenia and the representativeness of modern diagnostic criteria. JAMA Psychiatry 2016; 73: 1082-1092 DOI: 10.1001/jamapsychiatry.2016.1976.
• 5 Solmi M, Pigato GG, Roiter B. et al. Prevalence of catatonia and its moderators in clinical samples: results from a metaanalysis and meta-regression analysis. Schizophr Bull 2018; 44: 1133-1150 DOI: 10.1093/schbul/sbx157.
• 6 Walther S, Stegmayer K, Wilson JE. et al. Structure and neural mechanisms of catatonia. Lancet Psychiatry 2019; 6: 610-619 DOI: 10.1016/S2215-0366(18)30474-7.
• 7 Tandon R, Heckers S, Bustillo J. et al. Catatonia in DSM-5. Schizophr Res 2013; 150: 26-30 DOI: 10.1016/j.schres.2013.04.034.
• 8 Walther S, Strik W.. Catatonia. Cns Spectrums 2016; 21: 341-348 DOI: 10.1016/j.euroneuro.2021.11.008.
• 9 Heckers S, Walther S. Caring for the patient with catatonia. JAMA Psychiatry 2021; 78: 560-561 DOI: 10.1001/jamapsychiatry.2021.0096.
• 10 Benarous X, Raffin M, Ferrafiat V. et al. Catatonia in children and adolescents: New perspectives. Schizophr Res 2018; 200: 56-67 DOI: 10.1016/j.schres.2017.07.028.
• 11 Stuivenga M, Morrens M. Prevalence of the catatonic syndrome in an acute inpatient sample. Front Psychiatry 2014; 5: 174 DOI: 10.3389/fpsyt.2014.00174.
• 12 Walther S, Strik W. Catatonia. CNS Spectr 2016; 21: 341-348 DOI: 10.1016/j.euroneuro.2021.11.008.
• 13 Bush G, Fink M, Petrides G. et al. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand 1996; 93: 129-136 DOI: 10.1111/j.1600-0447.1996.tb09814.x.
• 14 Wilson JE, Niu K, Nicolson SE. et al. The diagnostic criteria and structure of catatonia. Schizophr Res 2015; 164: 256-262 DOI: 10.1016/j.schres.2014.12.036.
• 15 van der Heijden FM, Tuinier S, Arts NJM. et al. Catatonia: disappeared or under-diagnosed?. Psychopathol 2005; 38: 3-8 DOI: 10.1159/000083964.
• 16 Yeoh SY, Roberts E, Scott F. et al. Catatonic episodes related to substance use: A cross-sectional study using electronic healthcare records. J Dual Diagn 2022; 18: 52-58 DOI: 10.1080/15504263.2021.2016342.
• 17 Rogers JP, Pollak TA, Begum N. et al. Catatonia: demographic, clinical and laboratory associations. Psychol Med 2021; 1-11 DOI: 10.1017/S0033291721004402.
• 18 Rosebush PI, Hildebrand AM, Furlong BG. et al. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990; 51: 357-362
• 19 Viher PV, Stegmayer K, Federspiel A. et al. Altered diffusion in motor white matter tracts in psychosis patients with catatonia. Schizophr Res 2020; 220: 210-217 DOI: 10.1016/j.schres.2020.03.017.
• 20 Hirjak D, Rashidi M, Kubera KM. et al. Multimodal magnetic resonance imaging data fusion reveals distinct patterns of abnormal brain structure and function in catatonia. Schizophr Bull 2020; 46: 202-210 DOI: 10.1093/schbul/sbz042.
• 21 Walther S, Schäppi L, Federspiel A. et al. Resting-state hyperperfusion of the supplementary motor area in catatonia. Schizophr Bull 2017; 43: 972-981 DOI: 10.1093/schbul/sbw140.
• 22 Janova H, Arinrad S, Balmuth E. et al. Microglia ablation alleviates myelin-associated catatonic signs in mice. J Clin Invest 2018; 128: 734-745 DOI: 10.1172/JCI97032.
• 23 Ungvariv GS, Chiu HF, Chow LY. et al. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacol (Berl) 1999; 142: 393-398
• 24 Walther S, Alexaki D, Schoretsanitis G. et al. Inhibitory repetitive transcranial magnetic stimulation to treat psychomotor slowing: A transdiagnostic, mechanism-based randomized double-blind controlled trial. Schizophrenia Bull Open 2020; 1 DOI: 10.1093/schizbullopen/sgaa020.